fundvisualizer.com

Davis Appreciation & Income CDCSCX

Performance (before sales charge)

As of 04/30/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2022
Stock
64.81%
Non-U.S. Stock
14.17%
Bond
16.51%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
4.51%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2022

Basic materials

0.00%

Consumer cyclical

2.57%

Financial services

43.49%

Real estate

0.00%

Consumer defensive

0.00%

Health care

10.09%

Utilities

0.00%

Communication services

5.77%

Energy

0.00%

Industrials

3.12%

Technology

13.94%

Top 10 holdings

As of 12/31/2022

Berkshire Hathaway Inc Class B
8.19%
Wells Fargo & Co
5.50%
Alphabet Inc Class C
4.94%
Capital One Financial Corp
4.88%
Applied Materials Inc
4.82%
Cash & Equivalents
4.51%
Texas Instruments Inc
4.13%
Quest Diagnostics Inc
3.69%
Julius Baer Gruppe AG
3.55%
Viatris Inc
3.45%
Fund assets

$191.64 Million

Share class

C

Morningstar category

Moderately Aggressive Allocation

Expense ratio

1.75%

Investment objective

Growth and Income

Documents